These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35043958)

  • 1. The variant rs77559646 associated with aggressive prostate cancer disrupts ANO7 mRNA splicing and protein expression.
    Wahlström G; Heron S; Knuuttila M; Kaikkonen E; Tulonen N; Metsälä O; Löf C; Ettala O; Boström PJ; Taimen P; Poutanen M; Schleutker J
    Hum Mol Genet; 2022 Jun; 31(12):2063-2077. PubMed ID: 35043958
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Kaikkonen E; Ettala O; Nikulainen I; Taimen P; Lehtinen I; Boström PJ; Kellokumpu-Lehtinen PL; Schleutker J
    Anticancer Res; 2019 Oct; 39(10):5353-5359. PubMed ID: 31570429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANO7 is associated with aggressive prostate cancer.
    Kaikkonen E; Rantapero T; Zhang Q; Taimen P; Laitinen V; Kallajoki M; Jambulingam D; Ettala O; Knaapila J; Boström PJ; Wahlström G; Sipeky C; Pursiheimo JP; Tammela T; Kellokumpu-Lehtinen PL; ; Fey V; Maehle L; Wiklund F; Wei GH; Schleutker J
    Int J Cancer; 2018 Nov; 143(10):2479-2487. PubMed ID: 30157291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcripts of the Prostate Cancer-Associated Gene
    Metsälä O; Wahlström G; Taimen P; Kellokumpu-Lehtinen PL; Schleutker J
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer.
    Marx A; Koopmann L; Höflmayer D; Büscheck F; Hube-Magg C; Steurer S; Eichenauer T; Clauditz TS; Wilczak W; Simon R; Sauter G; Izbicki JR; Huland H; Heinzer H; Graefen M; Haese A; Schlomm T; Bernreuther C; Lebok P; Bonk S
    Cancer Biol Med; 2021 Feb; 18(1):245-255. PubMed ID: 33628598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANO7 African-ancestral genomic diversity and advanced prostate cancer.
    Jiang J; Soh PXY; Mutambirwa SBA; Bornman MSR; Haiman CA; Hayes VM; Jaratlerdsiri W
    Prostate Cancer Prostatic Dis; 2023 Sep; ():. PubMed ID: 37749167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAP1 missense mutation c.2054 A>T (p.E685V) completely disrupts normal splicing through creation of a novel 5' splice site in a human mesothelioma cell line.
    Morrison A; Chekaluk Y; Bacares R; Ladanyi M; Zhang L
    PLoS One; 2015; 10(4):e0119224. PubMed ID: 25830670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ANO7: Insights into topology, function, and potential applications as a biomarker and immunotherapy target.
    Guo J; Wang D; Dong Y; Gao X; Tong H; Liu W; Zhang L; Sun M
    Tissue Cell; 2021 Oct; 72():101546. PubMed ID: 33940566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interactome of the prostate-specific protein Anoctamin 7.
    Kaikkonen E; Takala A; Pursiheimo JP; Wahlström G; Schleutker J
    Cancer Biomark; 2020; 28(1):91-100. PubMed ID: 32176628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
    Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
    Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers.
    Phillips JW; Pan Y; Tsai BL; Xie Z; Demirdjian L; Xiao W; Yang HT; Zhang Y; Lin CH; Cheng D; Hu Q; Liu S; Black DL; Witte ON; Xing Y
    Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5269-5279. PubMed ID: 32086391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-nucleotide polymorphism rs13426236 contributes to an increased prostate cancer risk via regulating MLPH splicing variant 4.
    Xiao F; Zhang P; Wang Y; Tian Y; James M; Huang CC; Wang L; Wang L
    Mol Carcinog; 2020 Jan; 59(1):45-55. PubMed ID: 31659808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score.
    Sinha AA; Quast BJ; Korkowski JC; Wilson MJ; Reddy PK; Ewing SL; Sloane BF; Gleason DF
    Anticancer Res; 1999; 19(4B):2821-9. PubMed ID: 10652560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SF3B2-Mediated RNA Splicing Drives Human Prostate Cancer Progression.
    Kawamura N; Nimura K; Saga K; Ishibashi A; Kitamura K; Nagano H; Yoshikawa Y; Ishida K; Nonomura N; Arisawa M; Luo J; Kaneda Y
    Cancer Res; 2019 Oct; 79(20):5204-5217. PubMed ID: 31431456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the c.793-1G > A splicing variant in CHEK2 gene as pathogenic: a case report.
    Agiannitopoulos K; Papadopoulou E; Tsaousis GN; Pepe G; Kampouri S; Kocdor MA; Nasioulas G
    BMC Med Genet; 2019 Jul; 20(1):131. PubMed ID: 31349801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data.
    Shen S; Park JW; Lu ZX; Lin L; Henry MD; Wu YN; Zhou Q; Xing Y
    Proc Natl Acad Sci U S A; 2014 Dec; 111(51):E5593-601. PubMed ID: 25480548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding human DNA variants affecting pre-mRNA splicing in the NGS era.
    Dufner-Almeida LG; do Carmo RT; Masotti C; Haddad LA
    Adv Genet; 2019; 103():39-90. PubMed ID: 30904096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDH1 Missense Variant c.1679C>G (p.T560R) Completely Disrupts Normal Splicing through Creation of a Novel 5' Splice Site.
    Yelskaya Z; Bacares R; Salo-Mullen E; Somar J; Lehrich DA; Fasaye GA; Coit DG; Tang LH; Stadler ZK; Zhang L
    PLoS One; 2016; 11(11):e0165654. PubMed ID: 27880784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intron retention: a common splicing event within the human kallikrein gene family.
    Michael IP; Kurlender L; Memari N; Yousef GM; Du D; Grass L; Stephan C; Jung K; Diamandis EP
    Clin Chem; 2005 Mar; 51(3):506-15. PubMed ID: 15650036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Analysis of AR Variant AR-V567es mRNA Detection Systems Reveals Eminent Variability and Questions the Role as a Clinical Biomarker in Prostate Cancer.
    Bernemann C; Humberg V; Thielen B; Steinestel J; Chen X; Duensing S; Schrader AJ; Boegemann M
    Clin Cancer Res; 2019 Jul; 25(13):3856-3864. PubMed ID: 30992298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.